SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy’s Laboratories withdraws tizanidine tablets from US market

12 Apr 2013 Evaluate

Dr Reddy’s Laboratories has started withdrawing its muscle relaxant - tizanidine tablets, from the US market because of labeling issues. The entity has taken this decision after receiving the notification issued by United States Food and Drug Administration (FDA), and the same was intimated to the drug regulator through a letter on March 19.

The company has received the notification from FDA that, there is a possibility that the bottle labels do not contain the strength of the product as well as other printing details. Till the date 117,000 bottles are being recalled from the market by Dr Reddy’s Laboratories under a Class-III recall. The tablets are of 4 mg strength. 

Dr. Reddys Labs. Share Price

1269.80 -78.90 (-5.85%)
09-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1938.85
Dr. Reddys Labs. 1269.80
Cipla 1441.70
Zydus Lifesciences 1159.85
Lupin 2502.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: